These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11872376)

  • 1. Renal endothelial dysfunction and hypertension.
    Higashi Y; Chayama K
    J Diabetes Complications; 2002; 16(1):103-7. PubMed ID: 11872376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
    Circulation; 1998 Jun; 97(22):2222-9. PubMed ID: 9631871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary endothelial dysfunction: hypertension and heart failure.
    Boulanger CM
    J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between hypercholesterolaemia, endothelial dysfunction and hypertension.
    Hayakawa H; Raij L
    J Hypertens; 1999 May; 17(5):611-9. PubMed ID: 10403604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension.
    On YK; Kim CH; Oh BH; Lee MM; Park YB
    Hypertens Res; 2002 May; 25(3):365-71. PubMed ID: 12135314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction in essential hypertension.
    Panza JA
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-26-33. PubMed ID: 9422849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endothelial L-arginine/nitric oxide pathway and the renal circulation.
    Lüscher TF; Bock HA
    Klin Wochenschr; 1991 Sep; 69(13):603-9. PubMed ID: 1753683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelium and nitric oxide in childhood hypertension.
    Goonasekera CD; Dillon MJ
    Pediatr Nephrol; 1998 Oct; 12(8):676-89. PubMed ID: 9811394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy.
    Hayakawa H; Coffee K; Raij L
    Circulation; 1997 Oct; 96(7):2407-13. PubMed ID: 9337217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive drugs and reversing of endothelial dysfunction in hypertension.
    Taddei S; Virdis A; Ghiadoni L; Sudano I; Salvetti A
    Curr Hypertens Rep; 2000 Feb; 2(1):64-70. PubMed ID: 10981130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and endothelial dysfunction: therapeutic approach.
    Ghiadoni L; Taddei S; Virdis A
    Curr Vasc Pharmacol; 2012 Jan; 10(1):42-60. PubMed ID: 22112351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension.
    Higashi Y; Oshima T; Sasaki S; Nakano Y; Kambe M; Matsuura H; Kajiyama G
    Hypertension; 1998 Jul; 32(1):16-24. PubMed ID: 9674632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial function in hypertension.
    Mattei P; Virdis A; Ghiadoni L; Taddei S; Salvetti A
    J Nephrol; 1997; 10(4):192-7. PubMed ID: 9377726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of nitric oxide in hypertension and renal disease progression.
    Klahr S
    Nephrol Dial Transplant; 2001; 16 Suppl 1():60-2. PubMed ID: 11369823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced angiotensin-converting enzyme activity and impaired endothelium-dependent vasodilation in aortae from hypertensive rats: evidence for a causal link.
    Goetz RM; Holtz J
    Clin Sci (Lond); 1999 Aug; 97(2):165-74. PubMed ID: 10409471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of vascular endothelial function].
    Oshima T; Higashi Y; Ozono R; Nakano Y; Ishida M; Kambe M; Matsuura H; Kajiyama G
    Rinsho Byori; 2000 Sep; 48(9):860-6. PubMed ID: 11051805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.
    Taddei S; Virdis A; Ghiadoni L; Sudano I; Salvetti A
    Drugs; 2002; 62(2):265-84. PubMed ID: 11817973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of endothelial function by amlodipine and vitamin C in essential hypertension.
    On YK; Kim CH; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
    Korean J Intern Med; 2002 Jun; 17(2):131-7. PubMed ID: 12164090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.
    Panza JA; Casino PR; Badar DM; Quyyumi AA
    Circulation; 1993 May; 87(5):1475-81. PubMed ID: 8491002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production.
    Wassmann S; Laufs U; Stamenkovic D; Linz W; Stasch JP; Ahlbory K; Rösen R; Böhm M; Nickenig G
    Circulation; 2002 Apr; 105(17):2083-91. PubMed ID: 11980689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.